A Major Win for Truemeds
Mumbai-based healthtech startup Truemeds has just bagged a whopping $85 million (around INR 740 crore) in a Series C funding round, marking a huge milestone in its journey to make affordable medicines more accessible across India.
The round was backed by some of the biggest names in venture capital: Accel, Peak XV Partners, WestBridge Capital, and Info Edge Ventures.
Who…
India’s pharmaceutical landscape is evolving rapidly, with significant contributions to global healthcare highlighted at the 21st Indo-US Economic Summit. Rajeev Juneja, Vice Chairman and Managing Director of Mankind Pharma, emphasized the nation’s role in producing affordable, high-quality medicines, stating, “Every fourth tablet consumed globally is made in India. We have come a long way…
